Search - tctmd.com

Displaying 241 - 260 of 343

Sort: Relevancy | Date

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

News Daily News

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

January 09, 2019

The Biggest News of 2018: TCTMD’s Top 10

News Daily News

The Biggest News of 2018: TCTMD’s Top 10

December 31, 2018

Thienopyridines May Help ID Migraine Patients Best Suited to PFO Closure

News Daily News

Thienopyridines May Help ID Migraine Patients Best Suited to PFO Closure

Yael L. Maxwell

December 17, 2018

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

News Daily News

More Registry Data Show No Survival Advantage for Impella in Acute MI With Cardiogenic Shock

December 11, 2018

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

News Daily News

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

December 07, 2018

Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms

News Daily News

Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms

October 03, 2018

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

July 30, 2018

NOACs Particularly Beneficial for Women With A-fib, Study Suggests

News Daily News

NOACs Particularly Beneficial for Women With A-fib, Study Suggests

July 11, 2018

Spin to Win: Results From Late Breaking Meeting Trials Often Overstated

News Daily News

Spin to Win: Results From Late-Breaking Meeting Trials Often Overstated

May 15, 2018

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

News Daily News

Impella Use in Acute MI and Cardiogenic Shock: Clues From US Registry Data

April 12, 2018

Same-Day Discharge After Peripheral Interventions Gets Mixed Results in Pilot Study

News Daily News

Same-Day Discharge After Peripheral Interventions Gets Mixed Results in Pilot Study

March 22, 2018

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

News Daily News

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Michael O'Riordan

February 20, 2018

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

News Daily News

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

January 02, 2018

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

News Daily News

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

October 23, 2017

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

News Daily News

Impella Has Some Benefits in High-Risk PCI, but Clinical Impact Still Uncertain: Review

October 02, 2017

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

News Daily News

Data on IVC Filters Sparse but Somewhat Reassuring: Meta-Analysis

September 19, 2017

Infective Endocarditis Guidelines: The More the Merrier? Maybe Not

News Daily News

Infective Endocarditis Guidelines: The More the Merrier? Maybe Not

August 18, 2017

TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows

News Daily News

TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows

Michael O'Riordan

July 17, 2017

New-Generation DES Work Just Fine in Women With Acute MI

News Daily News

New-Generation DES Work Just Fine in Women With Acute MI

June 29, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.